Copyright
©The Author(s) 2022.
World J Hepatol. Jan 27, 2022; 14(1): 62-79
Published online Jan 27, 2022. doi: 10.4254/wjh.v14.i1.62
Published online Jan 27, 2022. doi: 10.4254/wjh.v14.i1.62
Figure 1 Modification of hepatic and extrahepatic manifestations of chronic hepatitis C after therapy with direct acting agents.
Figure represents the main alterations modified by this treatment, as well as those factors that influence the risk: absence of follow-up, previous fibrosis stage, previous decompensation, ongoing liver injury or liver stiffness after sustained viral response. HCV: Hepatitis C virus; SVR: Sustained virologic response; Kpa: Kilopascals.
- Citation: Cuesta-Sancho S, Márquez-Coello M, Illanes-Álvarez F, Márquez-Ruiz D, Arizcorreta A, Galán-Sánchez F, Montiel N, Rodriguez-Iglesias M, Girón-González JA. Hepatitis C: Problems to extinction and residual hepatic and extrahepatic lesions after sustained virological response. World J Hepatol 2022; 14(1): 62-79
- URL: https://www.wjgnet.com/1948-5182/full/v14/i1/62.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i1.62